Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-093063
Filing Date
2025-07-02
Accepted
2025-07-02 16:33:22
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3305
  Complete submission text file 0000950170-25-093063.txt   4840
Mailing Address C/O MEDIMMUNE, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 251101769

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)